We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take ...

We recently compiled a list of the 12 Best Big Name Stocks to Invest in Now. In this article, we are going to take a look at ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nanosonics Limited (NNCSF – Research Report) and Eli Lilly ...

Eli Lilly and Company (NYSE: LLY) and Scorpion Therapeutics, Inc. ("Scorpion"), a private biotechnology company developing small molecule precision oncology therapies, today announced a definitive ...

We recently published a list of Jim Cramer’s February Portfolio: Top 10 Stocks. In this article, we are going to take a look at where Eli Lilly And Company (NYSE:LLY) stands against other stocks ...

Indeed, the company's pipeline is impressive overall. What to Expect From Blockbuster GLP-1 Treatments Much of Eli Lilly's momentum in recent quarters has been due to Mounjaro and Zepbound.

Inc., AbCellera Biologics Inc.; Verge Genomics; and Chugai Pharmaceutical Co., Ltd, as well as development collaboration with Eli Lilly and Company for developing QIAstat-Dx IVD panel, for the ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Alibaba Group Holding Limited (BABA), Airbnb, Inc. (ABNB) and Royal Caribbean Cruises Ltd. (RCL), as well ...

Eli Lilly and ... Therapeutics Inc. is selling STX-478, its lead drug for breast cancer and other advanced solid tumors that is currently in a Phase 1/2 clinical trial. Lilly (NYSE: LLY) will ...

INDIANAPOLIS, Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE ... author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...